ONCY
#3897
Oncolytics Biotech Inc. - Common Stock
0.8 6 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.18%
Monthly Change
+13.16%
6 month change
-23.89%
Year Change
-17.31%
Previous Close
0.8 5
Open
0.8 6
Low
0.8 6
High
0.8 6
Volume
1
Financials
- Market Capitalization 109.66 M
- Employee 29
- Founded 1998
- CEO N/A
- Website www.oncolyticsbiotech.com
- Headquarter Nevada, United States
- FIGI BBG000DVS826
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.91
Price to sales ratio
-169.59
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3874 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.84 USD | -1.18% | -5.62% | -1.18% | +68.00% | 117.09 M USD | ||
| 3884 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.89 USD | -1.11% | -8.25% | -14.42% | +30.88% | 113.26 M USD | ||
| 3898 |  SEER Seer, Inc. - Class A Common Stock | 1.98 USD | -1.49% | -3.88% | -4.35% | -3.41% | 109.64 M USD | ||
| 3907 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.59 USD | -5.56% | -11.90% | +16.50% | -32.00% | 107.67 M USD |
Frequently asked questions about Oncolytics Biotech, Inc. Common Shares
What is the Oncolytics Biotech, Inc. Common Shares stock price today?
The current price of Oncolytics Biotech, Inc. Common Shares (ONCY) is 0.86. Over the past 24 hours, the stock has changed by +1.18%. Follow the ONCY chart for real-time price dynamics.
What is the stock ticker of Oncolytics Biotech, Inc. Common Shares?
Oncolytics Biotech, Inc. Common Shares trades under the ticker ONCY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Oncolytics Biotech, Inc. Common Shares stock going up?
ONCY has changed by +2.38% over the last week, +13.16% over the last month, and -17.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Oncolytics Biotech, Inc. Common Shares?
Oncolytics Biotech, Inc. Common Shares currently has a market capitalization of 109.66 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Oncolytics Biotech, Inc. Common Shares earnings last quarter?
Last quarter, Oncolytics Biotech, Inc. Common Shares reported earnings of -0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Oncolytics Biotech, Inc. Common Shares revenue for the last quarter?
Oncolytics Biotech, Inc. Common Shares reported quarterly revenue of 1 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Oncolytics Biotech, Inc. Common Shares net income for the last quarter?
Oncolytics Biotech, Inc. Common Shares reported net income of -9.44 M for the last quarter. The previous quarter showed -9.24 M, which means net income changed by -2.15%.
How many employees does Oncolytics Biotech, Inc. Common Shares have?
As of the latest available data, Oncolytics Biotech, Inc. Common Shares has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Oncolytics Biotech, Inc. Common Shares EBITDA?
Oncolytics Biotech, Inc. Common Shares EBITDA is -9.36 M, and its EBITDA margin is -936.3 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Oncolytics Biotech, Inc. Common Shares stock?
You can buy Oncolytics Biotech, Inc. Common Shares (ONCY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Oncolytics Biotech, Inc. Common Shares stock?
Investing in Oncolytics Biotech, Inc. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ONCY chart and related analysis on metatrader.com as part of your research.